Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREVALENCE AND CHARACTERISTICS OF TRANSTHYRETIN AMYLOIDOSIS IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY OF UNKNOWN ETIOLOGY TTRACK

NCT03842163 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03842163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03842163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREVALENCE AND CHARACTERISTICS OF TRANSTHYRETIN AMYLOIDOSIS IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY OF UNKNOWN ETIOLOGY TTRACK
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 9, 2018
Completion date
June 8, 2022
Enrollment
812 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin amyloidosis cardiomyopathy (attr-cm)